641 related articles for article (PubMed ID: 20725949)
1. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
Salim SY; Söderholm JD
Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of IBD associated diarrhea.
Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
[TBL] [Abstract][Full Text] [Related]
3. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
[TBL] [Abstract][Full Text] [Related]
4. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
5. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
7. Mucosal cytokine network in inflammatory bowel disease.
Andoh A; Yagi Y; Shioya M; Nishida A; Tsujikawa T; Fujiyama Y
World J Gastroenterol; 2008 Sep; 14(33):5154-61. PubMed ID: 18777592
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
Hering NA; Schulzke JD
Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
[TBL] [Abstract][Full Text] [Related]
9. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
Mankertz J; Schulzke JD
Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
[TBL] [Abstract][Full Text] [Related]
10. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.
Miner-Williams WM; Moughan PJ
Nutr Res Rev; 2016 Jun; 29(1):40-59. PubMed ID: 27087106
[TBL] [Abstract][Full Text] [Related]
11. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
Michielan A; D'Incà R
Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
[TBL] [Abstract][Full Text] [Related]
13. Intestinal barrier dysfunction in inflammatory bowel diseases.
McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
[TBL] [Abstract][Full Text] [Related]
14. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
15. Epithelial tight junctions in intestinal inflammation.
Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and functional implications of intestinal barrier defects.
Shen L; Su L; Turner JR
Dig Dis; 2009; 27(4):443-9. PubMed ID: 19897958
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis as a therapeutic paradigm in inflammatory bowel diseases.
Verstege MI; te Velde AA; Hommes DW
Acta Gastroenterol Belg; 2006; 69(4):406-12. PubMed ID: 17343084
[TBL] [Abstract][Full Text] [Related]
18. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease.
Schürmann G; Brüwer M; Klotz A; Schmid KW; Senninger N; Zimmer KP
Int J Colorectal Dis; 1999 Feb; 14(1):41-6. PubMed ID: 10207729
[TBL] [Abstract][Full Text] [Related]
19. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
Uhlig HH
Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
[TBL] [Abstract][Full Text] [Related]
20. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
Amasheh M; Grotjohann I; Amasheh S; Fromm A; Söderholm JD; Zeitz M; Fromm M; Schulzke JD
Scand J Gastroenterol; 2009; 44(10):1226-35. PubMed ID: 19658020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
